Cancer With Few or No Early Symptoms: Why Screening Matters

Some cancers grow for a long time without causing any symptoms. This page explains why that happens, which cancers can be found early by screening, and how to notice changes without living in fear.

A tumor causes symptoms when it presses on something, blocks something, bleeds, or changes how an organ works. Early on, many tumors do none of these. They sit in a space with room to spare, in an organ that keeps working, and nothing hurts.

Location matters as much as size. NCI gives several reasons pancreatic cancer is hard to detect early. One is that the pancreas is obscured by other organs in the abdomen and is difficult to see clearly on imaging tests.

No symptoms does not mean no disease. Often it just means early.

Pancreatic cancer. NCI states that there are no noticeable signs or symptoms in the early stages, which makes it hard to detect. When signs are present, they are like the signs of many other illnesses. Symptoms as the cancer grows include jaundice (yellowing of the skin and the whites of the eyes), light-colored stools, dark urine, pain in the upper or middle abdomen and back, weight loss for no known reason, loss of appetite and fatigue.

Kidney cancer. NCI's summary of renal cell cancer says there may be no signs or symptoms in the early stages. Signs and symptoms may appear as the tumor grows. Later signs include blood in the urine, a lump in the abdomen, a pain in the side that does not go away, loss of appetite, weight loss for no known reason and anemia.

Lung cancer. NCI states that sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. When symptoms do appear, they include a cough that does not go away or gets worse, chest discomfort or pain, trouble breathing, wheezing, blood in sputum, hoarseness, trouble swallowing, loss of appetite, unexplained weight loss and fatigue.

Ovarian cancer. There is no standard screening test. NCI says screening for ovarian cancer may not help a person live longer. It also says that using CA-125 blood levels together with transvaginal ultrasound does not decrease the number of deaths from the disease.

Real disease, no symptoms, worse outcomes when found late. That pattern is the whole reason screening exists. Screening looks for cancer before a person has any symptoms. That is the only window in which a silent cancer can be caught at all.

But screening helps only under one condition. A test has to exist that finds the disease early enough, and reliably enough, to change what happens afterward. That condition is met for some cancers and not others. The difference has nothing to do with how carefully anyone is paying attention.

NCI lists the screening tests shown to reduce deaths. Mammography for breast cancer, shown to reduce breast cancer deaths among women ages 40 to 74. HPV and Pap testing for cervical cancer. Colonoscopy, sigmoidoscopy and stool tests for colorectal cancer. And low-dose CT for lung cancer in people who have smoked heavily.

Of the four cancers above, lung cancer is the only one with a screening test recommended for a defined group.

The US Preventive Services Task Force recommends annual screening with low-dose computed tomography for adults aged 50 to 80 who have a 20 pack-year smoking history and who either currently smoke or quit within the past 15 years. That is a grade B recommendation, issued in March 2021.

The criteria are narrow and specific. People outside them are not covered by the recommendation. That is a statement about the populations the trials studied, not about who deserves attention.

For ovarian and pancreatic cancer, the Task Force recommends against screening people at average risk. That is not an oversight. It reflects what the evidence showed.

Ovarian. The Task Force recommends against screening asymptomatic women who are not known to have a high-risk hereditary cancer syndrome, such as a BRCA1 or BRCA2 mutation. It is a grade D recommendation from February 2018. Three large trials found no reduction in ovarian cancer deaths. Calculated false-positive rates ranged from roughly 4 percent to 44 percent, depending on the test and the number of screening rounds. Some false positives led to surgery in women who did not have cancer. Up to 15 percent of those women had major surgical complications.

Pancreatic. The Task Force recommends against screening asymptomatic adults not known to be at high risk. That is a grade D recommendation from August 2019. It found no evidence that screening improves mortality. It also described the accuracy of current candidate screening tests as uncertain.

Kidney. Kidney cancer does not appear on NCI's list of cancers with screening tests shown to reduce deaths.

A grade D means a body of evidence concluded that the harms outweigh the benefits for people at average risk. It says nothing about people with a strong family history or a known genetic syndrome. They fall outside these recommendations and are usually managed differently.

Every symptom listed above is common, and is usually caused by something other than cancer. Abdominal pain, fatigue, cough and appetite changes are among the most frequent reasons people see a doctor at all.

Two features tend to matter more than the symptom itself: persistence and change. Something that keeps going for weeks without an obvious explanation is worth describing to a clinician. So is a clear shift from what is normal for you. Say how long it has lasted, and whether it is getting worse. Bringing dates rather than impressions makes the conversation more useful.

That is a different activity from scanning yourself for disaster. Constant self-surveillance is exhausting. It does not surface anything that a plain description of a persistent change would miss. The useful version is low-effort. Notice it. Note when it started. Say so.

• Does my family history or any known genetic condition place me outside average-risk recommendations?
• Do I meet the criteria for lung cancer screening, and what would it involve?
• I have had this symptom for several weeks. What could explain it, and what would help rule things out?
• If a scan done for another reason showed an incidental finding, how would that be followed up?

• Call 911 or go to an emergency department if you cough up more than a few teaspoons of blood, or coughing up any blood comes with chest pain, severe breathlessness, dizziness or a fever (MedlinePlus). Do not drive yourself.
• Call your care team the same day if your skin or the whites of your eyes turn yellow, particularly alongside dark urine or pale stools (MedlinePlus). Also call the same day if you cough up any amount of blood. MedlinePlus says to contact your provider any time you do.
• Call your care team within a day or two if you see blood in your urine, or a cough, hoarseness, side or upper-belly pain, appetite loss or unexplained weight loss has carried on for several weeks without a clear reason.

• National Cancer Institute — What Cancer Screening Tests Check for Cancer?
• MedlinePlus — Coughing up blood
• MedlinePlus — Jaundice
• National Cancer Institute — Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening (PDQ)
• National Cancer Institute — Pancreatic Cancer Treatment (PDQ), Health Professional Version
• National Cancer Institute — Renal Cell Cancer Treatment (PDQ), Patient Version
• National Cancer Institute — Non-Small Cell Lung Cancer Treatment (PDQ), Patient Version
• U.S. Preventive Services Task Force — Ovarian Cancer: Screening
• U.S. Preventive Services Task Force — Pancreatic Cancer: Screening
• U.S. Preventive Services Task Force — Lung Cancer: Screening